Table 1

Cohort characteristics

NI cohortNI, no GERDNI+GERDP value
n (%)10 30975372772
Age at NI (mean (SD))4.15 (5.82)4.65 (6.07)2.79 (4.84)<0.001
Gender (F)4738 (46.0)3483 (46.2)1255 (45.3)0.578
CCC
 Cardiovascular1589 (15.4)951 (12.6)638 (23.0)<0.001
 Metabolic743 (7.2)429 (5.7)314 (11.3)<0.001
 Renal/urologic665 (6.5)398 (5.3)267 (9.6)<0.001
 Genetic/congenital2656 (25.8)1787 (23.7)869 (31.3)<0.001
 Neonatal1678 (16.3)1200 (15.9)478 (17.2)0.114
 Gastrointestinal663 (6.4)381 (5.1)282 (10.2)<0.001
 Haemat/immunol444 (4.3)226 (3.0)218 (7.9)<0.001
 Respiratory485 (4.7)182 (2.4)303 (10.9)<0.001
 Malignancy603 (5.8)391 (5.2)212 (7.6)<0.001
No of CCC<0.001
 04323 (41.9)3488 (46.3)835 (30.1)
 13651 (35.4)2697 (35.8)954 (34.4)
 21509 (14.6)957 (12.7)552 (19.9)
 3547 (5.3)279 (3.7)268 (9.7)
 4+279 (2.7)116 (1.5)163 (5.9)
Technology
 Tracheostomy75 (0.7)28 (0.4)47 (1.7)<0.001
 Evacuation tube467 (4.5)325 (4.3)142 (5.1)0.089
 Gastrostomy1359 (13.2)406 (5.4)953 (34.3)<0.001
 Renal support203 (2.0)140 (1.9)63 (2.3)0.206
No of technology<0.001
 08160 (79.2)6528 (86.6)1632 (58.9)
 11965 (19.1)952 (12.6)1013 (36.5)
 2+184 (1.8)57 (0.8)127 (4.6)
  • CCC, complex, chronic conditions; GERD, gastro-oesophageal reflux disease; NI, neurological impairment.